A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

NCT01489826 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumour

Interventions

DRUG: Dexanabinol
OTHER: Cremophor

Sponsor

e-Therapeutics PLC